China SXT Pharmaceuticals Statistics
Total Valuation
SXTC has a market cap or net worth of $1.33 million. The enterprise value is -$7.04 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
SXTC has 3.48 million shares outstanding. The number of shares has increased by 224.91% in one year.
Current Share Class | 3.48M |
Shares Outstanding | 3.48M |
Shares Change (YoY) | +224.91% |
Shares Change (QoQ) | +145.95% |
Owned by Insiders (%) | 11.80% |
Owned by Institutions (%) | 1.35% |
Float | 3.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.17 |
Forward PS | n/a |
PB Ratio | 0.06 |
P/TBV Ratio | 0.10 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.27.
Current Ratio | 1.60 |
Quick Ratio | 1.51 |
Debt / Equity | 0.27 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.78 |
Financial Efficiency
Return on equity (ROE) is -21.65% and return on invested capital (ROIC) is -6.34%.
Return on Equity (ROE) | -21.65% |
Return on Assets (ROA) | -4.96% |
Return on Capital (ROIC) | -6.34% |
Revenue Per Employee | $25,713 |
Profits Per Employee | -$41,314 |
Employee Count | 75 |
Asset Turnover | 0.07 |
Inventory Turnover | 1.98 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 1.16 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.57 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 29.93 |
Average Volume (20 Days) | 163,112 |
Short Selling Information
Short Interest | 105,303 |
Short Previous Month | 196,013 |
Short % of Shares Out | 2.68% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.22 |
Income Statement
In the last 12 months, SXTC had revenue of $1.93 million and -$3.10 million in losses. Loss per share was -$3.57.
Revenue | 1.93M |
Gross Profit | 553,971 |
Operating Income | -2.09M |
Pretax Income | -14.14M |
Net Income | -3.10M |
EBITDA | -1.89M |
EBIT | -2.09M |
Loss Per Share | -$3.57 |
Full Income Statement Balance Sheet
The company has $12.07 million in cash and $3.70 million in debt, giving a net cash position of $8.38 million or $2.41 per share.
Cash & Cash Equivalents | 12.07M |
Total Debt | 3.70M |
Net Cash | 8.38M |
Net Cash Per Share | $2.41 |
Equity (Book Value) | 13.93M |
Book Value Per Share | 6.28 |
Working Capital | 5.33M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$1.93 million and capital expenditures -$7,063, giving a free cash flow of -$1.94 million.
Operating Cash Flow | -1.93M |
Capital Expenditures | -7,063 |
Free Cash Flow | -1.94M |
FCF Per Share | -$0.56 |
Full Cash Flow Statement Margins
Gross margin is 28.73%, with operating and profit margins of -108.49% and -160.67%.
Gross Margin | 28.73% |
Operating Margin | -108.49% |
Pretax Margin | -160.67% |
Profit Margin | -160.67% |
EBITDA Margin | -97.95% |
EBIT Margin | -108.49% |
FCF Margin | -540.69% |